Pet M&A Just Doubled. 18 Deals in Q1 2026 Signal the Thaw Operators Have Been Waiting For.

The pet industry's M&A freeze is over. Capstone Partners' March 2026 sector update shows 18 announced or completed transactions in year-to-date 2026, more than double the eight recorded in the same period last year. Strategic buyer activity tripled from 3 to 10 deals. Vet and health companies are the most sought-after targets, accounting for half of all transactions. After two years of elevated interest rates, cautious buyers, and a thin deal pipeline, the pent-up demand that dealmakers kept predicting is finally materializing.

What Happened

Capstone Partners, the investment bank that tracks pet sector M&A more closely than any other advisory firm, published its latest Pet Sector Update in March. The numbers tell the story: 18 transactions in YTD 2026 versus 8 in YTD 2025 — a 125% increase in deal volume.

The deals are concentrated in three segments. Vet & Health led with nine transactions, followed by Food with six and Services with three. Notably absent: Products and Retail/Distribution, which have yet to record a single deal in 2026. That gap likely reflects the tariff uncertainty hitting product companies hardest, while services and healthcare businesses — which are largely domestic and immune to import costs — remain attractive.

Strategic buyers accounted for all 10 private acquisitions, a sharp increase from just three in the same period last year. Public company dealmakers are showing optimism too — Central Garden & Pet and Vimian have both signaled active M&A postures. Vimian's CEO specifically mentioned increased momentum with four active verticals pursuing bolt-on and platform acquisitions.

Private equity activity, while quieter, is expected to accelerate. Capstone notes three platform deals and five add-on transactions so far in 2026, already exceeding the five total PE deals recorded in all of YTD 2025. The firm anticipates a stronger pipeline of PE-backed assets coming to market through 2026 and 2027, driven by fund lifecycle pressures, LP demand for distributions, and an improving exit environment.

Notable transactions include the Capstone-advised sale of Ultra Pet to Oil-Dri Corporation of America, Instinct Science's acquisition of AI vet scribe ScribbleVet, and Paw Prosper's acquisition of the Canine Rehabilitation Institute.

Why It Matters

1. The vet and health segment is pulling away as the category's M&A center of gravity. Nine of 18 deals — exactly half — targeted vet and health companies. This isn't new, but the concentration is intensifying. Veterinary clinic networks captured roughly 40% of all pet tech funding in recent years, per Tracxn data, and NVA alone has completed six acquisitions in 2026. The thesis is clear: recurring revenue, defensive demand, and consolidation economics make vet businesses the most bankable assets in pet.

2. Food deals are heating up after a slow 2025. Six food transactions in the first quarter suggest the deal log jam is breaking. PetfoodIndustry has been tracking this trend, noting that several assets that were held back in 2025 due to valuation gaps and rate uncertainty are now coming to market. With pet food and treats generating $68.3 billion in U.S. sales — the largest segment of the $158 billion industry — even modest M&A acceleration in food represents significant capital deployment.

3. The Products and Retail gap is telling. Zero transactions in Products or Retail/Distribution isn't a coincidence. Product companies face the most direct tariff exposure, with 145% duties on Chinese imports reshaping their cost structures in real time. Buyers are understandably cautious about acquiring businesses whose margin profiles are in flux. This segment may remain frozen until tariff policy stabilizes or companies demonstrate they can pass costs through without losing volume.

4. Strategic buyers are back, and they're outpacing PE. The 3-to-10 jump in strategic acquisitions signals that corporate development teams have reactivated. When strategics lead deal flow, it typically means the acquirers see operational synergies and market positioning opportunities that justify paying up. For founders considering exits, a strategic-heavy market often means better valuations than a PE-dominated one.

5. The PE wave is still building. Fund managers sitting on pet-sector portfolio companies with 5-7 year hold periods are approaching the natural exit window. LP pressure for distributions is real. Capstone expects this to create a steady stream of assets hitting the market through 2027. For operators looking to acquire, this means more deal flow and potentially more realistic seller expectations.

What to Watch

Q2 deal volume. If the pace holds, 2026 could reach 50-70+ pet sector transactions, which would make it the most active year since the 2021-2022 boom. Watch for whether the momentum continues or if tariff uncertainty slows the pipeline in the back half of the year.

Products segment reactivation. The zero-deal freeze in Products won't last forever. When tariff policy stabilizes or companies demonstrate they can manage the new cost structure, expect pent-up deal activity here too. The first major product acquisition will be a signal that buyers are pricing in the new tariff reality.

Public company M&A. Central Garden & Pet and Vimian have signaled intent. A marquee acquisition from either — or from Freshpet, Chewy, or another public pet company — would set valuation benchmarks for the rest of the market.

Vet consolidation pricing. With nine vet deals already in Q1, pricing and multiples in the segment will come under scrutiny. If multiples remain elevated despite broader market caution, it confirms the segment's defensive premium. If they compress, it could signal that even vet consolidation has limits.

Source: Capstone Partners Pet Sector Update, March 2026